Trading the stockmarket (NO Referrals)

I have noticed shareprice.co.uk report more extreme prices, for very brief moments, than most other places. Take RKH, for example, on the random price drop day: shareprice.co.uk reported a price of 62.5p for a while. Most other places have no record of this, though I saw it, and trades were made at or near that price.

I wonder why?
 
Last edited:
All those low prices mean is that a trade has gone through at that price.

For those 2 it'll just be one poor sod who got screwed over when selling on either of the days when those 2 shares dropped a lot, kept going into auction etc.

No-one will have bought at those prices, but someone got screwed by their broker on a sell :)
 
Ev0 said:
All those low prices mean is that a trade has gone through at that price.

For those 2 it'll just be one poor sod who got screwed over when selling on either of the days when those 2 shares dropped a lot, kept going into auction etc.

No-one will have bought at those prices, but someone got screwed by their broker on a sell :)
Click to expand...

Could also mean that your data vendor is ****

Btw.. the middle part of your post and the last bit of your post are logically a bit flawed - if one party did sell at a particular price then of course some other counterparty bought at that price....
 
If anyone is looking for a good site to get up to date share prices ADVN is pretty good. That is what i have been using. Would also watch out with BP lots of people are seeing it as a get rich quick share but dunno whether that will actually be the case.
 
I'm going to buy shares tomorrow for the first time. I'm about to join investor interactive unless anyone is going to tell me not to? Going to open a stocks and shares is this one.
 
Woo - GWP going up again this morning after the below offical RNS


GW Pharmaceuticals cannabis-based drug Sativex approved

A ground-breaking cannabis-based drug for treating symptoms of multiple sclerosis has been approved in Britain, in a landmark decision for its creator GW Pharmaceuticals.

By Rachel Cooper, City Reporter
Published: 8:11PM BST 18 Jun 2010

The Aim-listed biotech company has been developing Sativex, which uses compounds extracted from marijuana plants, for more than a decade and has finally been granted a licence from the UK regulator.

Clinical trials have shown that Sativex, which is sprayed under the tongue, reduces spasticity in multiple sclerosis patients who do not respond adequately to existing therapies.

It became the world's first cannabis medicine to win regulatory clearance when it was approved in Canada in 2005 for neuropathic pain, but its roll-out in Britain – and other European markets thereafter – is a larger sales opportunity.

Last month, GW Pharmaceuticals indicated that the medicine would be approved by the end of June, with the final stages of the approval process involving only finalising product's packaging.

At the time, Dr Geoffrey Guy, chairman of GW, said: "The first six months of this year have proven the most important in GW's history, in which we have made material progress towards Sativex's launch in Europe and generated positive cancer pain data."

Although the market was anticipating approval in late June, Friday's news sent shares up 11pc to a four-year high of 143p in early afternoon trading. By the bell, shares were up 12 – or 9.3pc – to 141p.

A regulatory green light in Spain is expected shortly after the British approval.

Sativex is to be marketed in Britain by Germany's Bayer and in the rest of Europe by Spain's Almirall.

Analysts at Piper Jaffray have previously said that UK regulatory approval would trigger the first commercial sales and a £10m milestone payment from Bayer.

The broker anticipates that sales of Sativex in multiple sclerosis spasticity could reach £121m in Europe and Canada alone.
Click to expand...

Been holding them since I bought in at 77p so happy days!!
 
dowie said:
Tis slightly ironic - sticking a few K in some small cap stock and then getting lucky when it goes up a bit is very different to actively trading. People such as the OP are actively avoiding reliance on luck and will try to find exploitable inefficiencies in the markets that they can repeatedly use to their advantage. If you're utilizing a strategy in which you'll be executing many trades again and again then in the long term luck plays no part. If you're sticking a few k into some small cap stock (regardless of the research you've done) your return is often mostly reliant on luck.
Click to expand...

Regardless of how you trade or what you base your trades on an element of luck is present in even the most thought out transactions.

Whilst some (most?) of us are taking a few k punts on some stocks based on company research and future prospects I fail to see how this is a problem / issue (unless I’m reading the tone of your post incorrectly), I don't want to do in depth market research to look for gaps and inefficiencies in a particular market / sector, I want to read about a company, look at its future prospects both short and long term and then decide based on the current SP if its worth me putting some money into it, I wouldn't say that’s "mostly" luck.

I have to say at the moment it’s paying off and I’m up by a nice amount from when I started.
 
dowie said:
Btw.. the middle part of your post and the last bit of your post are logically a bit flawed - if one party did sell at a particular price then of course some other counterparty bought at that price....
Click to expand...

I know I know, every sell means there's a buy and vice versa, but you know what I mean :)
 
Looks like pulling out of RKH is working well ;)

Down to 278 i pulled out around 290, RRL on the up and NTOG a little static really.

Fingers crossed RKH keeps going down so i can buy back in soon.
 
You must log in or register to reply here.
Back
Top Bottom